• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
ABIOMED, Inc. (ABMD) - Product Pipeline Analysis - Product Image

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

  • ID: 1412651
  • August 2012
  • 51 pages
  • GlobalData

FEATURED COMPANIES

  • CardiacAssist, Inc.
  • CircuLite, Inc.
  • Jarvik Heart, Inc.
  • Levitronix LLC
  • Teleflex Incorporated
  • Thoratec Corporation
  • MORE

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

Summary

ABIOMED, Inc. (Abiomed) is a medical device company that focuses on the goal of establishing heart recovery against all acute cardiac attacks. It is a provider of heart support and recovery products used by healthcare professionals. Abiomed is the only company in the world that has an exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The company is one of the leading providers of products in the acute heart failure market and transports more number of ventricle assist devices (VADs) than any other company in the world.

In June 2012, the company received Health Canada approval to market the Impella cVAD device, a percutaneous Impella heart pump that provides peak flow of approximately 4 liters of blood per minute. In April 2012, the company also received CE Marking approval for Impella cVAD device.

The company operates in a single reportable segment namely, Research, Development and Sale of Medical Devices to support or replace the pumping function of the failing heart. Its products are utilized in a wide range of clinical settings by the READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CardiacAssist, Inc.
  • CircuLite, Inc.
  • Jarvik Heart, Inc.
  • Levitronix LLC
  • Teleflex Incorporated
  • Thoratec Corporation
  • MORE

List of Tables
List of Figures
ABIOMED, Inc. - Business Description
Key Facts
ABIOMED, Inc. - Major Products and Services
ABIOMED, Inc. Pipeline Products by Equipment Type
ABIOMED, Inc. Pipeline Products by Development Stage
ABIOMED, Inc. Pipeline Products by Therapy Area
ABIOMED, Inc. Pipeline Products by Trial Phase
ABIOMED, Inc. Pipeline Products by Milestone Summary
AbioCor II
AbioCor II Product Status
AbioCor II Product Description
AbioCor II Product Milestone
AbioCor II Product Patent Details
Impella cVAD
Impella cVAD Product Status
Impella cVAD Product Description
Impella cVAD Product Milestone
Impella cVAD Clinical Trial
Impella LP 2.5 - PCI
Impella LP 2.5 - PCI Product Status
Impella LP 2.5 - PCI Product Description
Impella LP 2.5 - PCI Clinical Trial
Impella Pediatric Pump
Impella Pediatric Pump Product Status
Impella Pediatric Pump Product Description
Impella RP
Impella RP Product Status
Impella RP Product Description
Impella RP Product Milestone
Symphony Heart Pump
Symphony Heart Pump Product Status
Symphony Heart Pump Product Description
Symphony Heart Pump Product Milestone
Symphony Heart Pump Clinical Trial
ABIOMED, Inc. - Key Competitors
ABIOMED, Inc. - Key Employees
ABIOMED, Inc. - Key Employee Biographies
ABIOMED, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ABIOMED, Inc., Recent Developments
Aug 02, 2012: Abiomed Reports Revenue Of $38.6m In Fiscal 2013
May 16, 2012: Abiomed Reports Revenue Of $126.4m In Fiscal 2012
Mar 21, 2012: Abiomed Appoints Susan Vissers Lisa As Senior Director Of Investor Relations And Corporate Development
Feb 03, 2012: Abiomed Reports Revenue Of $32.2m In Q3 Fiscal 2012
Dec 09, 2011: Abiomed Announces Expanded Heart Recovery Strategy With Multi Year Growth Initiatives
Dec 07, 2011: Abiomed To Release New Data And Product Updates At Investor & Analyst Day On December 9
Nov 09, 2011: PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit The Most From Impella Support: Abiomed
Nov 07, 2011: Abiomed Announces Inclusion Of Hemodynamic Support With Impella In ACCF/AHA/SCAI 2011
Nov 03, 2011: Abiomed Reports Revenues Of $29.5m In Q2 Fiscal 2012
Oct 27, 2011: Abiomed To Release New Protect II Data And Economic Study Results At TCT 2011; Over 20 Impella Presentations Included In Show Schedule
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
ABIOMED, Inc., Key Facts
ABIOMED, Inc. Key Pipeline Products by Equipment Type
ABIOMED, Inc. Key Pipeline Products by Therapy Area
ABIOMED, Inc. Key Pipeline Products by Development Stage
ABIOMED, Inc. Key Pipeline Products by Trial Phase
ABIOMED, Inc., Key Facts
ABIOMED, Inc., Major Products and Services
ABIOMED, Inc. Number of Pipeline Products by Equipment Type
ABIOMED, Inc. Pipeline Products by Equipment Type
ABIOMED, Inc. Number of Pipeline Products by Development Stage
ABIOMED, Inc. Pipeline Products by Development Stage
ABIOMED, Inc. Number of Pipeline Products by Therapy Area
ABIOMED, Inc. Pipeline Products by Therapy Area
ABIOMED, Inc. Number of Pipeline Products by Trial Phase
ABIOMED, Inc. Pipeline Products by Trial Phase
ABIOMED, Inc. Number of Pipeline Products By Milestone Summary
ABIOMED, Inc. Pipeline Products by Milestone Summary
AbioCor II - Product Status
AbioCor II - Product Description
AbioCor II - Product Milestone
AbioCor II - Patent Details1
AbioCor II - Patent Details2
AbioCor II - Patent Details3
Impella cVAD - Product Status
Impella cVAD - Product Description
Impella cVAD - Product Milestone
Impella cVAD - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Impella LP 2.5 - PCI - Product Status
Impella LP 2.5 - PCI - Product Description
Impella LP 2.5 - PCI - PROTECT II: A Prospective, Multi-Center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump (IABP)in Patients Undergoing Non Emergent High Risk PCI
Impella LP 2.5 - PCI - RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Impella LP 2.5 - PCI - To Evaluate Safety And Feasibility Of Left Ventricular Support With The Impella 2.5 During High-Risk Percutaneous Coronary Intervention (PCI) And Treatment Of Acute Myocardial Infarction
Impella LP 2.5 - PCI - A Multi-Center, Randomized Trial Of The Impella Recover LP 2,5 (left ventricular assist) Device Versus Intra Aortic Balloon Counter Pulsation (IABP) Therapy For Large anterior Acute ST-Elevation Myocardial Infarction Patients Treated With Primary PCI
Impella Pediatric Pump - Product Status
Impella Pediatric Pump - Product Description
Impella RP - Product Status
Impella RP - Product Description
Impella RP - Product Milestone
Symphony Heart Pump - Product Status
Symphony Heart Pump - Product Description
Symphony Heart Pump - Product Milestone
Symphony Heart Pump - First in Man Study - a Prospective, Multicenter, Single Arm Trial to Investigate the Safety and Feasibility of the Symphony Device
ABIOMED, Inc., Key Employees
ABIOMED, Inc., Key Employee Biographies
ABIOMED, Inc., Subsidiaries

List of Figures
ABIOMED, Inc. Pipeline Products by Equipment Type
ABIOMED, Inc. Pipeline Products by Development Stage
ABIOMED, Inc. Pipeline Products by Therapy Area
ABIOMED, Inc. Pipeline Products by Trial Phase
ABIOMED, Inc. Pipeline Products by Milestone Summary

Note: Product cover images may vary from those shown

MAQUET Cardiovascular, LLC
Teleflex Incorporated
Levitronix LLC
HeartWare International, Inc.
CircuLite, Inc.
CardiacAssist, Inc.
Thoratec Corporation
World Heart Corporation
Jarvik Heart, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos